Atopic Dermatitis Drugs Market Size Worth USD 25.20 Billion in 2032 | Emergen Research
December 28, 2023 08:04 ET
|
Emergen Research
Vancouver, Dec. 28, 2023 (GLOBE NEWSWIRE) -- The global atopic dermatitis drugs market size was USD 6.10 Billion in 2022 and is expected to register a rapid revenue CAGR of 15.2% during the forecast...
Covenantlabs Announces 'Covenant Child' Global OBT Pre-Registration Is Currently in Progress
December 11, 2023 01:20 ET
|
Covenant Labs CO.,LTD.
SEOUL, KOREA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Smart city integration platform company CityLabs' affiliated company, CovenantLabs, said pre-registration for OBT is currently in progress before...
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023
December 07, 2023 16:05 ET
|
Avid Bioservices, Inc
-- Recorded Second Quarter Revenue of $25.4 Million -- -- Signed $35 Million in Net New Business Orders Resulting in a Backlog of $199 Million -- -- Entered into Partnership with California...
Citylabs' Affiliated Company, Covenantlabs, 'Covenant Child' Global OBT Pre-Order Will Be Start
December 04, 2023 01:19 ET
|
Covenant Labs CO.,LTD.
SEOUL, KOREA, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Smart city integration platform company CityLabs' (139050.KQ) affiliated company, CovenantLabs, will begin pre-registration of 'Covenant Child' OBT,...
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023
November 30, 2023 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – BCLI
November 26, 2023 21:36 ET
|
The Rosen Law Firm PA
NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI)...
Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs
November 08, 2023 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Asia-Pacific Anti-inflammatory Therapeutics Market to Reach $40.5 Billion by 2032 With CAGR of 5.4%: Says Allied Market Research
November 05, 2023 18:55 ET
|
Allied Market Research
Wilmington, Delaware, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Asia-Pacific Anti-inflammatory Therapeutics Market, By Drug Class (Biologics, NSAIDs,...
Avid Bioservices Completes Construction of New, World-Class Cell and Gene Therapy Development and Manufacturing Facility
October 17, 2023 08:05 ET
|
Avid Bioservices, Inc
Avid completes construction of cell and gene theapy facility bringing total revenue generating capacity to up to ~$400 Million annually
Atopic Dermatitis Drugs Market Size to Surpass USD 28.2 billion by 2031, at a CAGR of 8.9% | Transparency Market Research Inc.
October 16, 2023 12:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. -The global atopic dermatitis drugs market is likely to develop at an 8.9% CAGR from 2023 to...